Search Results for: Hovione Expands Offering to Solve
Articles
October 1, 2012
Hovione Expands Offering to Solve Bioavailability & Other Delivery Challenges October 1, 2012
Hovione recently announced the expansion of its solutions to solve issues of poor bioavailability, patient acceptability, and the enabling of...
March 7, 2024
Hovione Partners With Dragonfly Technologies to Offer Micellar Chemistry Technology to Customers as a Sustainable Alternative to Conventional Chemical Processes March 7, 2024
Hovione recently announced it has signed an agreement with Dragonfly Technologies, Inc. to gain access to its micellar technology for chemistry-in-water...
October 1, 2012
10/3/2012 October 1, 2012
Actinium Announces Multi-Million Financing Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a...
October 15, 2013
BIOAVAILABILITY ENHANCEMENT - Navigating a Broad Spectrum of Solubilization Technologies: Part II of III October 15, 2013
Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc., continues his multiple-part series discussing today’s most challenging issues in solubility.
November 29, 2012
12/5/2012 November 29, 2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
September 3, 2012
9/5/2012 September 3, 2012
Genmab Signs Potential Billion Dollar Agreement Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human...
June 25, 2012
6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...
